International Assets Investment Management LLC Sells 66,271 Shares of The Clorox Company $CLX

Key Points

• International Assets Investment Management LLC cut its Clorox stake by 65.4%, selling 66,271 shares and retaining 35,000 shares valued at approximately $2.84 million. Institutional investors collectively own 78.53% of the company.
• Clorox reported quarterly earnings of $1.55 per share, well above the $1.07 analyst consensus, while revenue rose 33.3% year over year to $1.91 billion. The company declared a $1.25 quarterly dividend, equivalent to a 5.6% annualized yield.
• Analyst sentiment remains cautious, with a consensus “Reduce” rating and an average price target of $93.57. Although Evercore upgraded the stock to “in-line,” other firms lowered targets, and Clorox expects full-year earnings near the lower end of its $5.70–$6.00 range amid higher costs.

International Assets Investment Management LLC lowered its position in The Clorox Company (NYSE:CLX - Free Report) by 65.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 35,000 shares of the company's stock after selling 66,271 shares during the quarter. International Assets Investment Management LLC's holdings in Clorox were worth $2,835,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in CLX. BlackRock Inc. purchased a new stake in Clorox in the second quarter valued at approximately $958,640,000. Bank of America Corp DE purchased a new position in Clorox in the 2nd quarter worth approximately $179,780,000. Royal Bank of Canada boosted its position in Clorox by 20.1% during the 1st quarter. Royal Bank of Canada now owns 1,418,204 shares of the company's stock valued at $146,969,000 after buying an additional 237,301 shares during the period. Bank of New York Mellon Corp increased its position in shares of Clorox by 2.3% in the first quarter. Bank of New York Mellon Corp now owns 1,280,226 shares of the company's stock valued at $132,670,000 after acquiring an additional 29,181 shares during the period. Finally, Confluence Investment Management LLC increased its position in shares of Clorox by 33.8% in the second quarter. Confluence Investment Management LLC now owns 1,247,644 shares of the company's stock valued at $119,075,000 after acquiring an additional 315,069 shares during the period. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Trading Up 2.3%

Shares of CLX stock opened at $90.04 on Tuesday. The company has a debt-to-equity ratio of 15.80, a quick ratio of 0.38 and a current ratio of 0.66. The stock has a fifty day simple moving average of $88.27 and a two-hundred day simple moving average of $99.92. The firm has a market capitalization of $10.89 billion, a PE ratio of 15.68, a PEG ratio of 2.91 and a beta of 0.59. The Clorox Company has a 52-week low of $79.12 and a 52-week high of $128.90.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Monday, November 2nd. The company reported $1.55 earnings per share for the quarter, topping analysts' consensus estimates of $1.07 by $0.48. Clorox had a return on equity of 522.23% and a net margin of 8.74%. The firm had revenue of $1.91 billion during the quarter, compared to analyst estimates of $1.88 billion. During the same quarter in the prior year, the company posted $0.85 earnings per share. The business's quarterly revenue was up 33.3% compared to the same quarter last year. On average, analysts predict that The Clorox Company will post 5.66 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Wednesday, October 28th will be given a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 5.6%. The ex-dividend date is Wednesday, October 28th. Clorox's payout ratio is currently 103.73%.

Key Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Clorox reported fiscal Q1 adjusted earnings of $1.55 per share, well above the $1.07 consensus estimate and up from $0.85 a year earlier. Revenue increased 33.3% year over year, also exceeding expectations, supporting the stock’s upward move. Clorox Surpasses Q1 Earnings and Revenue Estimates
• Positive Sentiment: The results suggest Clorox’s earnings recovery is progressing, with strong sales growth and significantly improved year-over-year profitability. The company’s quarterly performance exceeded Wall Street expectations on both the top and bottom lines. Clorox Reports Q1 Fiscal Year 2027 Results
• Positive Sentiment: Evercore ISI upgraded CLX from “underperform” to “in-line” and assigned a $99 price target, citing the new CEO’s turnaround experience. The upgrade signals that some analysts see improving risk-reward potential after the stock’s recent weakness. Evercore ISI Upgrades Clorox
• Neutral Sentiment: Management said it expects full-year adjusted EPS of $5.70 to $6.00, but now anticipates results near the lower end of that range. This preserves the existing outlook while indicating limited near-term upside. Clorox Posts Higher Revenue and Profit
• Negative Sentiment: Higher costs remain a key concern. Clorox described the operating environment as challenging, and cost pressures could weigh on margins and prevent the strong quarterly beat from translating into a higher full-year forecast. Clorox Points to Challenging Cost Backdrop

Analysts Set New Price Targets

CLX has been the topic of a number of research analyst reports. JPMorgan Chase & Co. reduced their price target on Clorox from $95.00 to $83.00 and set an "underweight" rating on the stock in a report on Monday, October 19th. BNP Paribas Exane cut their price objective on Clorox from $97.00 to $95.00 and set a "neutral" rating on the stock in a research report on Monday, July 20th. Evercore raised Clorox from an "underperform" rating to an "in-line" rating and set a $99.00 target price on the stock in a research note on Monday. UBS Group set a $91.00 target price on Clorox in a report on Thursday, October 15th. Finally, TD Cowen dropped their price target on Clorox from $85.00 to $80.00 and set a "hold" rating for the company in a research note on Tuesday, October 13th. Twelve equities research analysts have rated the stock with a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of "Reduce" and a consensus price target of $93.57.

Clorox Profile

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt's Bees personal care items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.